Koninklijke Philips N.V.
Koninklijke Philips N.V. RYLPF Peers
See (RYLPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RYLPF | $22.41 | -3.50% | 20.7B | 77.28 | $0.29 | +4.09% |
| SEMHF | $55.30 | +0.36% | 62B | 26.46 | $2.09 | +2.03% |
| SMMNY | $26.19 | -1.13% | 58.7B | 25.18 | $1.04 | +0.99% |
| SONVY | $62.47 | -0.27% | 18.6B | 28.79 | $2.17 | +1.52% |
| SONVF | $311.34 | -1.27% | 18.6B | 28.64 | $10.87 | +1.88% |
| SNNUF | $14.30 | N/A | 12.5B | 30.43 | $0.47 | +2.62% |
| CHEOY | $88.24 | +1.43% | 11.6B | 48.48 | $1.82 | +1.62% |
| CHEOF | $170.00 | +1.19% | 11.1B | 46.96 | $3.62 | +1.63% |
| WILYY | $19.25 | N/A | 8.2B | 19.25 | $1.00 | N/A |
| WILLF | $36.25 | N/A | 7.5B | 18.13 | $2.00 | N/A |
Stock Comparison
RYLPF vs SEMHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SEMHF has a market cap of 62B. Regarding current trading prices, RYLPF is priced at $22.41, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SEMHF's P/E ratio is 26.46. In terms of profitability, RYLPF's ROE is +0.03%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, RYLPF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SMMNY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SMMNY has a market cap of 58.7B. Regarding current trading prices, RYLPF is priced at $22.41, while SMMNY trades at $26.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SMMNY's P/E ratio is 25.18. In terms of profitability, RYLPF's ROE is +0.03%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, RYLPF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SONVY has a market cap of 18.6B. Regarding current trading prices, RYLPF is priced at $22.41, while SONVY trades at $62.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SONVY's P/E ratio is 28.79. In terms of profitability, RYLPF's ROE is +0.03%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, RYLPF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SONVF has a market cap of 18.6B. Regarding current trading prices, RYLPF is priced at $22.41, while SONVF trades at $311.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SONVF's P/E ratio is 28.64. In terms of profitability, RYLPF's ROE is +0.03%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, RYLPF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNNUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SNNUF has a market cap of 12.5B. Regarding current trading prices, RYLPF is priced at $22.41, while SNNUF trades at $14.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SNNUF's P/E ratio is 30.43. In terms of profitability, RYLPF's ROE is +0.03%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CHEOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CHEOY has a market cap of 11.6B. Regarding current trading prices, RYLPF is priced at $22.41, while CHEOY trades at $88.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CHEOY's P/E ratio is 48.48. In terms of profitability, RYLPF's ROE is +0.03%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CHEOF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CHEOF has a market cap of 11.1B. Regarding current trading prices, RYLPF is priced at $22.41, while CHEOF trades at $170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CHEOF's P/E ratio is 46.96. In terms of profitability, RYLPF's ROE is +0.03%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, RYLPF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs WILYY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, WILYY has a market cap of 8.2B. Regarding current trading prices, RYLPF is priced at $22.41, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas WILYY's P/E ratio is 19.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, RYLPF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs WILLF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, RYLPF is priced at $22.41, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas WILLF's P/E ratio is 18.13. In terms of profitability, RYLPF's ROE is +0.03%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, RYLPF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNGBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, GNGBY has a market cap of 5.2B. Regarding current trading prices, RYLPF is priced at $22.41, while GNGBY trades at $19.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas GNGBY's P/E ratio is 34.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, RYLPF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMBFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, AMBFF has a market cap of 5.2B. Regarding current trading prices, RYLPF is priced at $22.41, while AMBFF trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas AMBFF's P/E ratio is 91.43. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNGBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, RYLPF is priced at $22.41, while GNGBF trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas GNGBF's P/E ratio is 36.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, RYLPF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NHNKY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, NHNKY has a market cap of 4.3B. Regarding current trading prices, RYLPF is priced at $22.41, while NHNKY trades at $13.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas NHNKY's P/E ratio is 22.72. In terms of profitability, RYLPF's ROE is +0.03%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NGMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, NGMDF has a market cap of 4.1B. Regarding current trading prices, RYLPF is priced at $22.41, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas NGMDF's P/E ratio is -4.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, RYLPF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMBBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, AMBBY has a market cap of 3.9B. Regarding current trading prices, RYLPF is priced at $22.41, while AMBBY trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas AMBBY's P/E ratio is 71.95. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NHNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, RYLPF is priced at $22.41, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VTRLY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, VTRLY has a market cap of 2.2B. Regarding current trading prices, RYLPF is priced at $22.41, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, RYLPF's ROE is +0.03%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, RYLPF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs OSSFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, RYLPF is priced at $22.41, while OSSFF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNNDY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, RYLPF is priced at $22.41, while GNNDY trades at $43.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas GNNDY's P/E ratio is 17.26. In terms of profitability, RYLPF's ROE is +0.03%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs STSEY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $22.41, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas STSEY's P/E ratio is 39.41. In terms of profitability, RYLPF's ROE is +0.03%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, RYLPF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GGNDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $22.41, while GGNDF trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas GGNDF's P/E ratio is 14.95. In terms of profitability, RYLPF's ROE is +0.03%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DWRKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $22.41, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, RYLPF's ROE is +0.03%, compared to DWRKF's ROE of N/A. Regarding short-term risk, RYLPF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MCRPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, MCRPF has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $22.41, while MCRPF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas MCRPF's P/E ratio is -7.82. In terms of profitability, RYLPF's ROE is +0.03%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, RYLPF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs OSSUY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $22.41, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, RYLPF's ROE is +0.03%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MEDGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $22.41, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, RYLPF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DRWKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, DRWKF has a market cap of 1.3B. Regarding current trading prices, RYLPF is priced at $22.41, while DRWKF trades at $70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas DRWKF's P/E ratio is 9.42. In terms of profitability, RYLPF's ROE is +0.03%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IMEXF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, IMEXF has a market cap of 1.2B. Regarding current trading prices, RYLPF is priced at $22.41, while IMEXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas IMEXF's P/E ratio is -0.17. In terms of profitability, RYLPF's ROE is +0.03%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DGWPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, RYLPF is priced at $22.41, while DGWPF trades at $55.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas DGWPF's P/E ratio is 7.51. In terms of profitability, RYLPF's ROE is +0.03%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs XVIPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, RYLPF is priced at $22.41, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, RYLPF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LFTSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, RYLPF is priced at $22.41, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, RYLPF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ELEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, RYLPF is priced at $22.41, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ELEAF's P/E ratio is 11.02. In terms of profitability, RYLPF's ROE is +0.03%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, RYLPF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MDRSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, MDRSF has a market cap of 638.4M. Regarding current trading prices, RYLPF is priced at $22.41, while MDRSF trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas MDRSF's P/E ratio is 151.47. In terms of profitability, RYLPF's ROE is +0.03%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, RYLPF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CALZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CALZF has a market cap of 559.2M. Regarding current trading prices, RYLPF is priced at $22.41, while CALZF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CALZF's P/E ratio is 80.95. In terms of profitability, RYLPF's ROE is +0.03%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, RYLPF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CLVSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, RYLPF is priced at $22.41, while CLVSF trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, RYLPF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LBLTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, LBLTF has a market cap of 496.1M. Regarding current trading prices, RYLPF is priced at $22.41, while LBLTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas LBLTF's P/E ratio is -1.22. In terms of profitability, RYLPF's ROE is +0.03%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AVMR Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, RYLPF is priced at $22.41, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas AVMR's P/E ratio is -18.34. In terms of profitability, RYLPF's ROE is +0.03%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, RYLPF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IOBCF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, IOBCF has a market cap of 404.3M. Regarding current trading prices, RYLPF is priced at $22.41, while IOBCF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas IOBCF's P/E ratio is 39.43. In terms of profitability, RYLPF's ROE is +0.03%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs HYBT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, RYLPF is priced at $22.41, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas HYBT's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, RYLPF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EAPIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, EAPIF has a market cap of 290.4M. Regarding current trading prices, RYLPF is priced at $22.41, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, RYLPF's ROE is +0.03%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, RYLPF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DMTRF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, DMTRF has a market cap of 276.8M. Regarding current trading prices, RYLPF is priced at $22.41, while DMTRF trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas DMTRF's P/E ratio is -35.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, RYLPF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CSSPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CSSPF has a market cap of 263.4M. Regarding current trading prices, RYLPF is priced at $22.41, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, RYLPF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs HTLZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, RYLPF is priced at $22.41, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, RYLPF's ROE is +0.03%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, RYLPF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CLLKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CLLKF has a market cap of 241.8M. Regarding current trading prices, RYLPF is priced at $22.41, while CLLKF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CLLKF's P/E ratio is -7.78. In terms of profitability, RYLPF's ROE is +0.03%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, RYLPF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CYBQY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CYBQY has a market cap of 216.3M. Regarding current trading prices, RYLPF is priced at $22.41, while CYBQY trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CYBQY's P/E ratio is -50.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, RYLPF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CYBQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, RYLPF is priced at $22.41, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, RYLPF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BCCOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, BCCOY has a market cap of 172.6M. Regarding current trading prices, RYLPF is priced at $22.41, while BCCOY trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas BCCOY's P/E ratio is -5.68. In terms of profitability, RYLPF's ROE is +0.03%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, RYLPF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BRNHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, BRNHF has a market cap of 161.8M. Regarding current trading prices, RYLPF is priced at $22.41, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, RYLPF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EKDHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, RYLPF is priced at $22.41, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs JMDMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, JMDMF has a market cap of 152M. Regarding current trading prices, RYLPF is priced at $22.41, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to JMDMF's ROE of N/A. Regarding short-term risk, RYLPF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AVHHL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, AVHHL has a market cap of 148.6M. Regarding current trading prices, RYLPF is priced at $22.41, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, RYLPF's ROE is +0.03%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, RYLPF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BRSYF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, BRSYF has a market cap of 128.4M. Regarding current trading prices, RYLPF is priced at $22.41, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, RYLPF's ROE is +0.03%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, RYLPF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VMTHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, RYLPF is priced at $22.41, while VMTHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, RYLPF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMEUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, RYLPF is priced at $22.41, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, RYLPF's ROE is +0.03%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, RYLPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PXMBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, PXMBF has a market cap of 120.1M. Regarding current trading prices, RYLPF is priced at $22.41, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, RYLPF's ROE is +0.03%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, RYLPF is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs FDMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, RYLPF is priced at $22.41, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, RYLPF's ROE is +0.03%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, RYLPF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IMPZY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, IMPZY has a market cap of 100M. Regarding current trading prices, RYLPF is priced at $22.41, while IMPZY trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas IMPZY's P/E ratio is -0.80. In terms of profitability, RYLPF's ROE is +0.03%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, RYLPF is less volatile compared to IMPZY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TCLIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, TCLIF has a market cap of 96.4M. Regarding current trading prices, RYLPF is priced at $22.41, while TCLIF trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas TCLIF's P/E ratio is -23.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to TCLIF's ROE of -0.74%. Regarding short-term risk, RYLPF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RSHUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, RYLPF is priced at $22.41, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, RYLPF's ROE is +0.03%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, RYLPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CKMTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, RYLPF is priced at $22.41, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, RYLPF's ROE is +0.03%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, RYLPF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SOMNF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SOMNF has a market cap of 79.4M. Regarding current trading prices, RYLPF is priced at $22.41, while SOMNF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SOMNF's P/E ratio is -12.25. In terms of profitability, RYLPF's ROE is +0.03%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, RYLPF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNZZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, SNZZF has a market cap of 73.2M. Regarding current trading prices, RYLPF is priced at $22.41, while SNZZF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas SNZZF's P/E ratio is -5.50. In terms of profitability, RYLPF's ROE is +0.03%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, RYLPF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IPDQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, IPDQF has a market cap of 68.1M. Regarding current trading prices, RYLPF is priced at $22.41, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas IPDQF's P/E ratio is -3.36. In terms of profitability, RYLPF's ROE is +0.03%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, RYLPF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RDGL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, RDGL has a market cap of 58.1M. Regarding current trading prices, RYLPF is priced at $22.41, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas RDGL's P/E ratio is -12.81. In terms of profitability, RYLPF's ROE is +0.03%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, RYLPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BLOZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, BLOZF has a market cap of 49.8M. Regarding current trading prices, RYLPF is priced at $22.41, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas BLOZF's P/E ratio is -21.61. In terms of profitability, RYLPF's ROE is +0.03%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, RYLPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CRRVF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, CRRVF has a market cap of 46.3M. Regarding current trading prices, RYLPF is priced at $22.41, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas CRRVF's P/E ratio is -0.01. In terms of profitability, RYLPF's ROE is +0.03%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NVYTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, RYLPF is priced at $22.41, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, RYLPF's ROE is +0.03%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, RYLPF is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TLTFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, TLTFF has a market cap of 37.2M. Regarding current trading prices, RYLPF is priced at $22.41, while TLTFF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas TLTFF's P/E ratio is -15.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, RYLPF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ELXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, RYLPF is priced at $22.41, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, RYLPF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EMITF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, EMITF has a market cap of 25.5M. Regarding current trading prices, RYLPF is priced at $22.41, while EMITF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas EMITF's P/E ratio is -16.43. In terms of profitability, RYLPF's ROE is +0.03%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs POSC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, POSC has a market cap of 24.7M. Regarding current trading prices, RYLPF is priced at $22.41, while POSC trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas POSC's P/E ratio is 0.37. In terms of profitability, RYLPF's ROE is +0.03%, compared to POSC's ROE of +9.25%. Regarding short-term risk, RYLPF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PLLWF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $22.41, while PLLWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, RYLPF is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs KBBTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $22.41, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to KBBTF's ROE of N/A. Regarding short-term risk, RYLPF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MDXHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, MDXHF has a market cap of 17.6M. Regarding current trading prices, RYLPF is priced at $22.41, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, RYLPF's ROE is +0.03%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, RYLPF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ASAPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ASAPF has a market cap of 17.3M. Regarding current trading prices, RYLPF is priced at $22.41, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ASAPF's P/E ratio is -22.20. In terms of profitability, RYLPF's ROE is +0.03%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, RYLPF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DIZTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, DIZTF has a market cap of 16.1M. Regarding current trading prices, RYLPF is priced at $22.41, while DIZTF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas DIZTF's P/E ratio is -10.00. In terms of profitability, RYLPF's ROE is +0.03%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, RYLPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PYNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, PYNKF has a market cap of 15.1M. Regarding current trading prices, RYLPF is priced at $22.41, while PYNKF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas PYNKF's P/E ratio is -0.77. In terms of profitability, RYLPF's ROE is +0.03%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, RYLPF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VPTDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, VPTDF has a market cap of 14.4M. Regarding current trading prices, RYLPF is priced at $22.41, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas VPTDF's P/E ratio is -4.41. In terms of profitability, RYLPF's ROE is +0.03%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, RYLPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TMDIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, RYLPF is priced at $22.41, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, RYLPF's ROE is +0.03%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, RYLPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ZMSPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ZMSPF has a market cap of 12.3M. Regarding current trading prices, RYLPF is priced at $22.41, while ZMSPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ZMSPF's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to ZMSPF's ROE of +0.82%. Regarding short-term risk, RYLPF is less volatile compared to ZMSPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ATBPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, RYLPF is priced at $22.41, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, RYLPF's ROE is +0.03%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, RYLPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LXXGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, RYLPF is priced at $22.41, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, RYLPF's ROE is +0.03%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, RYLPF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GTHP Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, GTHP has a market cap of 11M. Regarding current trading prices, RYLPF is priced at $22.41, while GTHP trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas GTHP's P/E ratio is -2.80. In terms of profitability, RYLPF's ROE is +0.03%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, RYLPF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RMSL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, RMSL has a market cap of 10.7M. Regarding current trading prices, RYLPF is priced at $22.41, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas RMSL's P/E ratio is 0.70. In terms of profitability, RYLPF's ROE is +0.03%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, RYLPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MKEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, MKEAF has a market cap of 9.6M. Regarding current trading prices, RYLPF is priced at $22.41, while MKEAF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas MKEAF's P/E ratio is -6.11. In terms of profitability, RYLPF's ROE is +0.03%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, RYLPF is less volatile compared to MKEAF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ALRTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ALRTF has a market cap of 8.9M. Regarding current trading prices, RYLPF is priced at $22.41, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ALRTF's P/E ratio is -0.47. In terms of profitability, RYLPF's ROE is +0.03%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, RYLPF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TBRIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, TBRIF has a market cap of 6.5M. Regarding current trading prices, RYLPF is priced at $22.41, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas TBRIF's P/E ratio is -1.44. In terms of profitability, RYLPF's ROE is +0.03%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, RYLPF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DTXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, RYLPF is priced at $22.41, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, RYLPF's ROE is +0.03%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, RYLPF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IRME Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, IRME has a market cap of 5.5M. Regarding current trading prices, RYLPF is priced at $22.41, while IRME trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas IRME's P/E ratio is -2.57. In terms of profitability, RYLPF's ROE is +0.03%, compared to IRME's ROE of +11.77%. Regarding short-term risk, RYLPF is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs QLIS Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, RYLPF is priced at $22.41, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas QLIS's P/E ratio is 2.22. In terms of profitability, RYLPF's ROE is +0.03%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, RYLPF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RHNMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, RYLPF is priced at $22.41, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, RYLPF's ROE is +0.03%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, RYLPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NUMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, NUMD has a market cap of 4.8M. Regarding current trading prices, RYLPF is priced at $22.41, while NUMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas NUMD's P/E ratio is 5.70. In terms of profitability, RYLPF's ROE is +0.03%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, RYLPF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MICR Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, RYLPF is priced at $22.41, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas MICR's P/E ratio is -3.47. In terms of profitability, RYLPF's ROE is +0.03%, compared to MICR's ROE of -0.25%. Regarding short-term risk, RYLPF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs FZMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, FZMD has a market cap of 4.6M. Regarding current trading prices, RYLPF is priced at $22.41, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas FZMD's P/E ratio is 1.24. In terms of profitability, RYLPF's ROE is +0.03%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, RYLPF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VYCO Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, VYCO has a market cap of 3.9M. Regarding current trading prices, RYLPF is priced at $22.41, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas VYCO's P/E ratio is -11.79. In terms of profitability, RYLPF's ROE is +0.03%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, RYLPF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ADMT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ADMT has a market cap of 3.8M. Regarding current trading prices, RYLPF is priced at $22.41, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ADMT's P/E ratio is -5.63. In terms of profitability, RYLPF's ROE is +0.03%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, RYLPF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BIEL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, RYLPF is priced at $22.41, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas BIEL's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, RYLPF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ESMC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, ESMC has a market cap of 3.4M. Regarding current trading prices, RYLPF is priced at $22.41, while ESMC trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas ESMC's P/E ratio is 9.16. In terms of profitability, RYLPF's ROE is +0.03%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, RYLPF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VANIW Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, RYLPF is priced at $22.41, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas VANIW's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.03%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, RYLPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PMEDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 20.7B. In comparison, PMEDF has a market cap of 3.1M. Regarding current trading prices, RYLPF is priced at $22.41, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 77.28, whereas PMEDF's P/E ratio is -2.03. In terms of profitability, RYLPF's ROE is +0.03%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, RYLPF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.